Specific combinations seem to be synergistic, such as DNMT3A and IDH1/2, as they frequently co-occur in AML [20], are associated with clonal dominance when they co-occur in single cells [196], and convey poorer prognosis compared to single-mutated cases [20,197]. This evidence concerns the gene DNMT3A and acute myeloid leukemia.